Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Mingde Healthcare Biotechnology is a Chinese company specializing in the production and export of biological products, oil chemicals, biochemical reagents and equipment. Its product portfolio includes testosterone series compounds, natural pigments, amino acids, fatty acids/esters/glycerine/dimer acid/polyamide/flavors/fragrances/solanesol/coenzyme Q10/isoflavone/protein flocculants/flocculant pectin/tobacco-use glue/pesticide solvent. These are widely used across pharmaceuticals/drug manufacturing as well as food/cosmetics/tobacco/plastics/leather industries. The company has multiple factories/sales outlets across China with its headquarters located in Wuhan’s East Lake High-Tech Zone. No clinical trial or drug development pipeline information is reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Mingde Healthcare Biotechnology.